Predictive Biomarkers of Severe Immune-Related Adverse Events With Immune Checkpoint Inhibitors: Prevention, Underlying Causes, Intensity, and Consequences

Immune checkpoint inhibitors (ICIs) have dramatically transformed oncology by prolonging overall survival and yielding better patient tolerance compared to other chemotherapeutic agents. However, numerous questions remain unanswered about the toxicity profile of ICIs, its relationship with the treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardeña-Gutiérrez, Ana, López Barahona, Mónica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237384/
https://www.ncbi.nlm.nih.gov/pubmed/35774996
http://dx.doi.org/10.3389/fmed.2022.908752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237384/
https://www.ncbi.nlm.nih.gov/pubmed/35774996
http://dx.doi.org/10.3389/fmed.2022.908752

Ejemplares similares